SCHEMBL1817593

SCHEMBL1817593

N#Cc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CCO3)cs1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR1H3 Q13133 1/20 0.46
▸ NPC1 O15118 1/20 0.43
▸ CYP2C9 P11712 2/20 0.41
▸ CPT1A P50416 4/20 0.40
▸ HTR6 P50406 4/20 0.40
▸ PKM P14618 2/20 0.40
▸ PKLR P30613 2/20 0.40
▸ CPT2 P23786 1/20 0.40
▸ CPT1B Q92523 3/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ USP30 Q70CQ3 1/20 0.39
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816941 0.90 CYP2C9 (0.53) NR1H3NPC1CYP2C9CPT1APKM
SCHEMBL1819206 0.90 PKM (0.42) NR1H3NPC1CYP2C9CPT1AHTR6
SCHEMBL1821637 0.89 PKM (0.48) NPC1CYP2C9PKMPKLRMEN1
SCHEMBL1817952 0.88 CYP11B1 (0.44) CYP2C9CPT1ACPT1BCYP11B1CYP11B2
SCHEMBL1817603 0.87 CYP2C9 (0.42) NR1H3NPC1CYP2C9CPT1APKM
SCHEMBL1819614 0.87 NPC1 (0.57) NPC1CYP2C9HTR6PKMPKLR
SCHEMBL1817317 0.87 CYP2C9 (0.44) NR1H3NPC1CYP2C9CPT1APKM
SCHEMBL12818236 0.85 PDE3B (0.35) NR1H3NPC1CYP2C9CPT1APKM
SCHEMBL1818362 0.84 PIK3CA (0.40) NPC1CYP2C9CPT1APKMPKLR
SCHEMBL12817789 0.83 PKM (0.42) NPC1CYP2C9CPT1APKMPKLR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback